gastric-cancer

Documents about gastric-cancer

• A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression#851906ClinicalTrials.gov
• Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer#897340ClinicalTrials.gov
• [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications#855742ClinicalTrials.gov
• T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers#474750ClinicalTrials.gov
• Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma#801477ClinicalTrials.gov
• WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy#829431ClinicalTrials.gov
• Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)#854061ClinicalTrials.gov
• A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors#917540ClinicalTrials.gov
• Single-cell atlas of gastric cancer reveals malignant epithelial evolution and regulatory reprogramming of the tumor microenvironment.#125439NCBI PubMed Central
• Integrative systems biology and drug repurposing reveal key regulatory hubs and a prognostic signature in gastric cancer.#288842NCBI PubMed Central
• Factors associated with self-care engagement among oesophageal and gastric cancer survivors: a population-based cross-sectional study.#312405NCBI PubMed Central
• Refrigerator Ownership and the Decline of Gastric Cancer: A Global Overview.#316334PubMed
• A stromal-derived five-gene signature predicts gastric cancer recurrence through integrated bioinformatics and single-cell analysis.#368074NCBI PubMed Central
• Validation of the GLIM Malnutrition Criteria in Patients With Gastric Cancer at the Time of Diagnosis.#465370NCBI PubMed Central
• Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization#876864ClinicalTrials.gov
• Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer#892299ClinicalTrials.gov
• Development and Validation of Perceived Fatigue Meaning Scale on Walking Program#912077ClinicalTrials.gov
• Global burden of disease for gastric cancer from 1990 to 2023 and projections of the burden to 2035.#923539NCBI PubMed Central
• Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors#160345ClinicalTrials.gov
• Pan-tumor MRD Study#917214ClinicalTrials.gov
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.#807674ClinicalTrials.gov
• Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies#803666ClinicalTrials.gov
• Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors#801963ClinicalTrials.gov
• Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer#804665ClinicalTrials.gov
• Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers#853918ClinicalTrials.gov
• Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies#906150ClinicalTrials.gov
• Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor#995283ClinicalTrials.gov
• A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer#911288ClinicalTrials.gov
• Clinical risk factors for multidrug-resistant organism infections in postoperative gastric cancer patients: an ICU-based retrospective analysis.#154323NCBI PubMed Central
• Impact of the family cohesion-centered frailty intervention on older gastric cancer patients: a non-randomized controlled trial.#159620NCBI PubMed Central
• Intraperitoneal Paclitaxel-Induced Eosinophil Recruitment as a Potential Mediator of Tumor Response in Peritoneal Metastases from Gastric Cancer.#193729NCBI PubMed Central
• Spatial omics and its applications for a tumour microenvironment characterization and precision medicine approach of gastric cancer.#362153NCBI PubMed Central
• A nomogram based on systemic inflammatory markers: development and validation for predicting postoperative overall survival in gastric cancer.#368066NCBI PubMed Central
• Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies#442106ClinicalTrials.gov
• Multidimensional decision support by artificial intelligence across the full workflow of endoscopic submucosal dissection for early gastric cancer.#630844NCBI PubMed Central
• Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers#811382ClinicalTrials.gov
• Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer#830131ClinicalTrials.gov
• A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors#890046ClinicalTrials.gov
• Supervivencia y complicaciones en pacientes adultos mayores con cáncer gástrico resecable según el número de ganglios linfáticos resecados: un estudio de cohorte#428420Repositorio institucional EdocUR
• Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours#833896ClinicalTrials.gov
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors#890578ClinicalTrials.gov
• A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy#894900ClinicalTrials.gov
• Gastric cancer survival prediction using artificial intelligence models based on electronic health records: a systematic review and meta-analysis.#351469NCBI PubMed Central
• Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors#363618ClinicalTrials.gov
• Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway#384090CiNii
• Advances in Helicobacter pylori-mediated oncogenic signaling pathways in gastric cancer: From pathological evolution to clinical application prospects (Review).#402569NCBI PubMed Central
• PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery#467585ClinicalTrials.gov
• Deletion of the MALAT1 RNA 3' end Promotes Transcript Decay and Inhibits Proliferation in Gastric and Breast Cancer Cells#627786bioRxiv / medRxiv
• Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus#894436ClinicalTrials.gov
• Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors#902052ClinicalTrials.gov